Skip to content

A prospective longitudinal observational study about aging-related neuropsychiatric symptoms and cognitive transition in the non-dementia elderly: Shanghai Cohort for Aging-related Neuropsychiatric Surveillance (SCANS)

A prospective longitudinal observational study about aging-related neuropsychiatric symptoms and cognitive transition in the non-dementia elderly: Shanghai Cohort for Aging-related Neuropsychiatric Surveillance (SCANS)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115239
Enrollment
Unknown
Registered
2025-12-24
Start date
2026-01-05
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimers disease and related dementias

Interventions

Mild Behavioral Impairment Group (MBI):None
Health Control Group:None

Sponsors

Shanghai Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: MBI Enrollment Criteria: 1. Age >=50 years and =50 years and <=80 years; 2. Signed informed consent; 3. Able to cooperate and complete neuropsychological scale assessments, biological sample collection, and imaging examinations. 4. Community-dwelling middle-aged and elderly individuals without a psychiatric diagnosis according to ICD-10 standards, matched for age and gender with the disease group, who have provided signed informed consent.

Exclusion criteria

Exclusion criteria: MBI Group Exclusion Criteria: 1. Cerebral infarction or cerebral hemorrhage; 2. Intracranial tumors, inflammation, traumatic brain injury, epilepsy, etc.; 3. White matter lesions caused by other reasons (e.g., multiple sclerosis, sarcoidosis, etc.); 4. Chronic diarrhea or malnutrition (vitamin deficiency), thyroid dysfunction, hepatic or renal insufficiency, history of blood transfusion, history of high-risk sexual behavior, alcoholism, carbon monoxide poisoning, severe cardiopulmonary disease, drug abuse, etc.; 5. Autism and other psychiatric disorders; 6. MRI contraindications (e.g., cardiac pacemaker, metal clips, etc.). Healthy Control Group Exclusion Criteria: 1. Individuals currently, previously, or suspected of having a mental disorder. 2. Presence of clinically significant diseases, such as a history of cardiovascular, hepatic, endocrine, gastrointestinal, metabolic, neurological, pulmonary, psychiatric, or oncological diseases, or any clinically significant condition or other evidence that the investigator believes poses a risk to the subject's safety or may interfere with the initiation, conduct, or completion of the study. 3. Subjects whom the investigator deems unsuitable to participate in this trial due to other factors.

Design outcomes

Primary

MeasureTime frame
Change of Mild Behavioral Impairment Score;Changes in Cognitive Function Scores;

Secondary

MeasureTime frame
Change of Severity of Depression;Change of Self-Rating Anxiety Score;Change of Social Function Score;Change of sleep sccore;Change of Activities of Daily Living;

Countries

China

Contacts

Public ContactLing Yue

Shanghai Mental Health Center

bellingthemoon@hotmail.com+86 180 1731 1249

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026